ATG5 Protein

ATG5 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ATG5 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Autophagy enhancers</td>
<td>Research</td>
</tr>
<tr>
<td class="label">ATG5 expression</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Autophagy inducers</td>
<td>[mTOR](/mechanisms/mtor-signaling-pathway) inhibition</td>
</tr>
<tr>
<td class="label">ATG5 modulators</td>
<td>Expression control</td>
</tr>
<tr>
<td class="label">Small molecule enhancers</td>
<td>Core autophagy</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/arm" style="color:#ef9a9a">ARM</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">965 edges</a></td>
</tr>
</table>

Atg5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

ATG5 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ATG5 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Autophagy enhancers</td>
<td>Research</td>
</tr>
<tr>
<td class="label">ATG5 expression</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Autophagy inducers</td>
<td>[mTOR](/mechanisms/mtor-signaling-pathway) inhibition</td>
</tr>
<tr>
<td class="label">ATG5 modulators</td>
<td>Expression control</td>
</tr>
<tr>
<td class="label">Small molecule enhancers</td>
<td>Core autophagy</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/arm" style="color:#ef9a9a">ARM</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">965 edges</a></td>
</tr>
</table>

Atg5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

Overview

ATG5 ([Autophagy](/entities/autophagy) Related 5) is a core autophagy protein essential for the formation of autophagosomes. It is a key component of the ATG12-ATG5 conjugation system, which is required for autophagosome biogenesis. ATG5 plays critical roles in cellular homeostasis and has been implicated in various neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's disease. [@yousefi2006]

Structure

ATG5 is a ~282 amino acid protein: [@kuma2007]

• Molecular weight: ~32 kDa
• Ubiquitin-like fold: Contains an ubiquitin-like fold for conjugation
• Interaction domains: Interacts with ATG12, ATG16L1, and Fas-associated death domain (FADD)

ATG12-ATG5 Conjugate

• ATG5 forms a covalent conjugate with ATG12
• This conjugation is irreversible and essential for autophagy
• ATG12-ATG5 then binds ATG16L1 to form the ATG12-ATG5-ATG16L1 complex

Normal Function

ATG5 is central to autophagy:

• Autophagosome formation: Essential for the expansion and closure of the autophagosome
• ATG12-ATG5-ATG16L1 complex: Functions as an E3-like enzyme for LC3 lipidation
• Selective autophagy: Involved in receptor-mediated selective autophagy
• Pre-autophagosomal structure (PAS): Critical for PAS organization

Non-Autophagic Functions

• [Apoptosis](/mechanisms/apoptosis) regulation: ATG5 can be cleaved by calpains to generate a pro-apoptotic fragment
• Immune signaling: Regulates type I interferon signaling
• Mitochondrial quality control: Essential for mitophagy

Role in Disease

Alzheimer's Disease

• ATG5 deficiency enhances amyloid-β accumulation
• Impaired autophagic flux observed in AD brains
• Reduced ATG5 expression correlates with disease severity

Parkinson's Disease

• ATG5 mutations associated with PD risk
• Essential for mitophagy of damaged mitochondria
• Impaired mitophagy contributes to dopaminergic neuron loss

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin-protein) impairs ATG5-mediated autophagy
• ATG5 overexpression reduces mutant [huntingtin](genes/htt) aggregation
• Therapeutic potential of autophagy enhancement

ALS

• Dysregulated autophagy in motor [neurons](/entities/neurons)
• ATG7 and ATG5 deficiency accelerates disease progression

Therapeutic Targeting

Key Publications

Molecular Mechanisms

Autophagosome Formation

ATG5 is central to autophagy:

• Conjugation system: Forms ATG5-ATG12 conjugate
• Phagophore expansion: Required for autophagosome formation
• LC3 lipidation: Facilitates ATG5-ATG12 as E3 ligase
• Selective autophagy: Works with receptor proteins

ATG5-ATG12 System

The ATG5-ATG12 conjugate:

• Forms via ATG7 (E1) and ATG10 (E2) enzymes
• Essential for autophagosome biogenesis
• Acts as E3-like enzyme for LC3/GABARAP lipidation
• Required for both bulk and selective autophagy

Regulation

ATG5 is regulated by:

• Transcriptional control
• Post-translational modifications
• Apoptotic cleavage (inactivates function)
• Interactions with viral proteins

Disease Associations

Neurodegeneration

ATG5 dysfunction in:

• [Alzheimer's disease](/diseases/alzheimers-disease): Impaired autophagic clearance
• Parkinson's disease: Reduced mitophagy
• ALS: Aggregate clearance defects

Cancer

• Often overexpressed in cancers
• May support tumor survival
• Autophagy can be protective or promotional

Therapeutic Targeting

Research Directions

• ATG5 in selective autophagy
• Developing autophagy modulators
• ATG5 in neuronal survival
• Viral manipulation of ATG5

Background

The study of Atg5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [ATG7 Protein](/proteins/atg7-protein)
• mTOR Pathway

External Links

• [UniProt: ATG5](https://www.uniprot.org/uniprot/Q9H1Y0)
• [PDB: ATG5-ATG12 Complex](https://www.ebi.ac.uk/pdbe/entry/pdb/4ml7)
• [NCBI Gene: ATG5](https://www.ncbi.nlm.nih.gov/gene/9479)
• [Autophagy Database](https://autophagy.info/)

References

Brain Atlas Resources

• Allen Human Brain Atlas: [ATG5 expression search- Allen Mouse Brain Atlas: [ATG5 search](https://mouse.brain-map.org/search/index.html?query=ATG5)

Pathway Diagram

The following diagram shows the key molecular relationships involving ATG5 Protein discovered through SciDEX knowledge graph analysis: